![Frederick Callori](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frederick Callori
Direktor/Vorstandsmitglied bei
LEONABIO, INC.
Vermögen: - $ am 30.06.2026
Profil
Frederick P.
Callori is Chairman & Chief Executive Officer at Neurosterix SA since 2024.
Holds the position of Independent Director at LeonaBio, Inc. starting 2026.
Serves as Director at CereVasc, Inc., Quellis Biosciences LLC, Zucara Therapeutics, Inc., and Polycore Therapeutics, Inc. Managing Director & Venture at Perceptive Advisors (Private Equity) since 2018.
Former Independent Director at Astria Therapeutics, Inc. from 2021 to 2026 and at Landos Biopharma, Inc. from 2021 to 2024.
Partner at Choate, Hall & Stewart LLP from 1998 to 2017.
Executive Vice President & Senior Partner at Xontogeny LLC from 2023 to 2024.
Educated at State University of New York at Binghamton (undergraduate) and Boston University School of Law (graduate).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LEONABIO, INC. -.--% | 23.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Frederick Callori
| Unternehmen | Position | Beginn |
|---|---|---|
| LEONABIO, INC. | Direktor/Vorstandsmitglied | 05.05.2026 |
CereVasc, Inc.
 CereVasc, Inc. Medical SpecialtiesHealth Technology Develops medical devices for neurological diseases | Direktor/Vorstandsmitglied | - |
Zucara Therapeutics, Inc.
 Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people | Direktor/Vorstandsmitglied | - |
Quellis Biosciences LLC
 Quellis Biosciences LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that develops antibody therapies | Direktor/Vorstandsmitglied | - |
Polycore Therapeutics, Inc.
 Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatment for central nervous system diseases | Direktor/Vorstandsmitglied | - |
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Private Equity Investor | 01.01.2018 |
Ehemalige bekannte Positionen von Frederick Callori
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 23.01.2026 |
Xontogeny LLC
 Xontogeny LLC Pharmaceuticals: MajorHealth Technology Operates biotech aggregator company | Corporate Officer/Principal | 01.12.2024 |
| LANDOS BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 23.05.2024 |
| ░░░░░░░ ░░░░ ░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Frederick Callori
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
36
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Choate, Hall & Stewart LLP
 Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
LeonaBio, Inc.
 LeonaBio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
State University of New York at Binghamton
 State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Law
 Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CereVasc, Inc.
CereVasc, Inc. Medical SpecialtiesHealth Technology Develops medical devices for neurological diseases | Health Technology |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Finance |
Landos Biopharma, Inc.
 Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Xontogeny LLC
Xontogeny LLC Pharmaceuticals: MajorHealth Technology Operates biotech aggregator company | Health Technology |
Quellis Biosciences LLC
Quellis Biosciences LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that develops antibody therapies | Health Technology |
Zucara Therapeutics, Inc.
Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people | Health Technology |
Polycore Therapeutics, Inc.
Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatment for central nervous system diseases | Health Technology |
Wählen Sie MarketScreener 
